Gergana Koleva Contributor Join the forum discussion on this post
April 13, 2011 FDA – Industry MDUFA III Reauthorization Meeting Purpose To discuss potential financial baselines for device process funding under MDUFA III, as well as discuss FDA’s proposal package. Join the forum discussion on this post
ReGen Biologics Inc. (RGBOQ) has sued the U.S. Food and Drug Administration while seeking to restore approval for a knee-repair device. The FDA recently rescinded its prior approval for the key ReGen product, called Menaflex, blocking the company’s access to the U.S. market. Although the FDA cleared that device in December 2008, the agency determined [...]
WASHINGTON (AP) — Government investigators say the Food and Drug Administration is putting patients at risk by approving sensitive medical devices such as hip joints and heart defibrillators under the same streamlined system intended for power wheelchairs, stitches and catheters. The Government Accountability Office told Congress Wednesday that the approvals remain a serious issue for [...]
Enter your email address below to receive updates each time we publish new content.
Is it time to update your social media policy?
By Karen M. Cheung With the Federation of State Medical Boards (FSMB) this week releasing new guidelines for physicians on this particular topic, FierceHealthcare is dedicating this week’s commentary to a round-up of the best practices to help hospitals draw on other policies to see what fits at their institutions. Join the forum discussion on this post
How to maintain physician professionalism in social media
by MARK RYAN, MD Art is not a mirror held up to reality but a hammer with which to shape it. – Bertolt Brecht Join the forum discussion on this post
The ethics of social media use for the medical profession
by Emily Lu At the end of the day, I do not see social media as an end to itself. Join the forum discussion on this post
